- Filed
- Aug 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 5, 2024 | 511.11M sh |
| Capex | Q2 2024 · Jun 30, 2024 | $64K |
| Capex | Q2 2024 · Jun 30, 2023 | $16K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $2.1M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.94M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $2.54M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $2.31M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $35.23M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $9.75M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $36.41M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $10.74M |
| Stock Issued | Q2 2024 · Mar 11, 2024 | 298.11M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $3.63M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $11.45M |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 256.93M sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 256.88M sh |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$4.07M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $12.31M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $14.89M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $16.94M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.02 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.02 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $613K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $1.36M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$2.74M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$4.97M |